Cargando…
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.
Background: The SARS-CoV-2 Delta variant (B.1.617.2) has been associated with more severe disease, particularly when compared to the Alpha variant. Most of this data, however, is from high income countries and less is understood about the variant’s disease severity in other settings, particularly in...
Autores principales: | Hussey, Hannah, Davies, Mary-Ann, Heekes, Alexa, Williamson, Carolyn, Valley-Omar, Ziyaad, Hardie, Diana, Korsman, Stephen, Doolabh, Deelan, Preiser, Wofgang, Maponga, Tongai, Iranzadeh, Arash, Engelbrecht, Susan, Wasserman, Sean, Schrueder, Neshaad, Boloko, Linda, Symons, Greg, Raubenheimer, Peter, Viljoen, Abraham, Parker, Arifa, Cohen, Cheryl, Jasat, Waasila, Lessells, Richard, Wilkinson, Robert J, Boulle, Andrew, Hsiao, Marvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663174/ https://www.ncbi.nlm.nih.gov/pubmed/37994361 http://dx.doi.org/10.12688/gatesopenres.13654.1 |
Ejemplares similares
-
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
por: Hussey, Hannah, et al.
Publicado: (2022) -
Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
por: Valley-Omar, Ziyaad, et al.
Publicado: (2022) -
No point in travel bans if countries with poor surveillance are ignored
por: Preiser, Wolfgang, et al.
Publicado: (2022) -
A tale of two waves: characteristics and outcomes of COVID-19 admissions during the Omicron-driven fourth wave in Cape Town, South Africa, and implications for the future
por: Moolla, Muhammad Saadiq, et al.
Publicado: (2022) -
So far, no novel SARS-CoV-2 variants from Beijing—and hopefully better scientific cooperation going forward
por: Preiser, Wolfgang, et al.
Publicado: (2023)